Erika Geihe Stanzl

Title: Innovations of Erika Geihe Stanzl

Introduction

Erika Geihe Stanzl is a notable inventor based in Stanford, California. She has made significant contributions to the field of biochemistry, particularly in the area of siRNA delivery systems. Her innovative work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Erika holds a patent for "Amphipathic co-oligomers for the delivery of siRNA." This patent describes co-oligomer compounds and their complexes with polyanions, such as siRNAs. The invention focuses on methods for delivering polynucleotides into cells. The co-oligomers consist of at least one lipophilic monomer and one hydrophilic monomer, which enhances the cell permeability of the siRNA. This technology aims to reduce the expression of target proteins, providing a method for treating conditions linked to specific protein expressions.

Career Highlights

Erika is affiliated with Leland Stanford Junior University, where she continues her research and development in innovative biochemistry solutions. Her work has garnered attention for its potential applications in gene therapy and molecular medicine.

Collaborations

Erika has collaborated with esteemed colleagues, including Christina Barnes Cooley and Robert M Waymouth. These partnerships have furthered her research and contributed to advancements in the field.

Conclusion

Erika Geihe Stanzl's contributions to siRNA delivery systems exemplify the intersection of innovation and practical application in biochemistry. Her work not only enhances our understanding of molecular interactions but also paves the way for future therapeutic developments.